The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry

CompletedOBSERVATIONAL

Enrollment

303

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions

Genetic Forms of Extreme Obesity

Trial Locations (2)

Nationwide Children's Hospital, Columbus

University of Alberta, Edmonton

All Listed Sponsors

lead

Rhythm Pharmaceuticals, Inc.

INDUSTRY

NCT03479437 - The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry | Biotech Hunter | Biotech Hunter